M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 0.7774 USD 3.34% Market Closed
Market Cap: $82.9m

During the last 3 months MaxCyte Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 54% over this period (open performance analysis).

The last transaction was made on Aug 13, 2025 by Douglas Richard , who bought 111k USD worth of MXCT shares.

Last Transactions:
Swirsky Douglas J
$+64.5k
Masoud Maher
$+102.9k
Erck Stanley C
$+137.2k
Brooke William W
$+64.5k
Douglas Richard
$+111k
Sandoval David I.
$-1.1k
Soleymannezhad Ali
$-3.9k
Swirsky Douglas J
$-22.1k
Johnston John Joseph
$-13.9k
Sandoval David I.
$-20.3k
Johnston John Joseph
$-12k
Johnston John Joseph
$-9.5k
Johnston John Joseph
$-1.9k
Erck Stanley C
$-177.4k
Johnston John Joseph
$-11.2k
Erck Stanley C
$-80.2k
Erck Stanley C
$-98.6k
Johnston John Joseph
$-11.5k
Erck Stanley C
$-118.2k
Erck Stanley C
$-73.5k
Johnston John Joseph
$-12.8k
Ross Thomas M.
$-77.9k
Ross Thomas M.
$-70.3k
Johnston John Joseph
$-14.2k
Ross Thomas M.
$-54.6k
Ross Thomas M.
$-79.8k
Johnston John Joseph
$-39.9k
Ross Thomas M.
$-136.5k
Masoud Maher
$+345.2k
Masoud Maher
$+143.8k
Johnston John Joseph
$-22k
Johnston John Joseph
$-23k
View All Transactions

During the last 3 months MaxCyte Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 54% over this period (open performance analysis).

The last transaction was made on Aug 13, 2025 by Douglas Richard , who bought 111k USD worth of MXCT shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
27k USD
3
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
5
480.2k USD
9-12
months
0
0 USD

MaxCyte Inc
Insider Trading Chart

MaxCyte Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

MaxCyte Inc
Last Insider Transactions

Global
Insiders Monitor

MaxCyte Inc
Glance View

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. The company is headquartered in Gaithersburg, Maryland. The company went IPO on 2016-03-29. The firm is focused on providing enabling platform technologies to advance cell-based research and development, as well as next-generation cell therapeutic discovery, development and commercialization. The firm has developed and commercialized its Flow Electroporation platform, which facilitates complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address the cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. Its ExPERT platform consists of three instruments, which are known as the ATx, STx and GTx. The firm has also developed CARMA, a therapeutic platform based on transfecting mRNA into unstimulated cells for the development of immune cell therapies.

MXCT Intrinsic Value
HIDDEN
Show

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top